Skip to main content
Top
Published in: Current Nutrition Reports 2/2014

01-06-2014 | Neurological Disease and Cognitive Function (G Logroscino, Section Editor)

Fish Consumption and the Risk of Stroke

Author: Tilman Kühn

Published in: Current Nutrition Reports | Issue 2/2014

Login to get access

Abstract

The early observation of a low prevalence of coronary heart disease and a high prevalence of hemorrhagic stroke in Inuit populations was attributed to a high habitual intake of seafood and marine-derived n-3 fatty acids leading to reduced platelet aggregation. Subsequent research in populations worldwide revealed that habitual fish intake may protect against ischemic stroke, and possibly even hemorrhagic stroke. Comprehensive meta-analyses of observational studies have recently suggested a benefit of fish consumption in the primary prevention of stroke for women, but not for men. However, the reason for potential heterogeneity by gender is largely unclear. Evidence from randomized trials is not available, and the role of fish consumption in the secondary prevention of stroke remains to be elucidated. Although recommendations to eat fish at least once or twice per week still seem reasonable from a health perspective, environmental issues related to declining fish stocks worldwide need to be considered.
Literature
1.
go back to reference Bjerregaard P, Dyerberg J. Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Int J Epidemiol. 1988;17(3):514–9.PubMedCrossRef Bjerregaard P, Dyerberg J. Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Int J Epidemiol. 1988;17(3):514–9.PubMedCrossRef
2.
go back to reference Feskens EJ, Kromhout D. Epidemiologic studies on Eskimos and fish intake. Ann N Y Acad Sci. 1993;683:9–15.PubMedCrossRef Feskens EJ, Kromhout D. Epidemiologic studies on Eskimos and fish intake. Ann N Y Acad Sci. 1993;683:9–15.PubMedCrossRef
4.••
go back to reference Xun P, Qin B, Song Y, Nakamura Y, Kurth T, Yaemsiri S, et al. Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2012;66(11):1199–207. doi:10.1038/ejcn.2012.133. First comprehensive meta-analysis of cohort data on fish consumption and stroke risk from 2012.PubMedCrossRef Xun P, Qin B, Song Y, Nakamura Y, Kurth T, Yaemsiri S, et al. Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2012;66(11):1199–207. doi:10.​1038/​ejcn.​2012.​133. First comprehensive meta-analysis of cohort data on fish consumption and stroke risk from 2012.PubMedCrossRef
5.••
go back to reference Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012;345:e6698. doi:10.1136/bmj.e6698. Second comprehensive meta-analysis of cohort data on fish consumption and stroke risk from 2012. Includes detailed subgroup analyses not only on fish consumption, but also on n-3 fatty acids.PubMedCentralPubMedCrossRef Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012;345:e6698. doi:10.​1136/​bmj.​e6698. Second comprehensive meta-analysis of cohort data on fish consumption and stroke risk from 2012. Includes detailed subgroup analyses not only on fish consumption, but also on n-3 fatty acids.PubMedCentralPubMedCrossRef
6.
go back to reference Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke. The Zutphen Study. Stroke. 1994;25(2):328–32.PubMedCrossRef Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke. The Zutphen Study. Stroke. 1994;25(2):328–32.PubMedCrossRef
7.••
go back to reference Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047–67. doi:10.1016/j.jacc.2011.06.063. Exhaustive review of the evidence on n-3 fatty acids and cardiovascular disease. Pathways through which n-3 fatty acids may affect cardiovascular parameters are described in detail.PubMedCrossRef Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047–67. doi:10.​1016/​j.​jacc.​2011.​06.​063. Exhaustive review of the evidence on n-3 fatty acids and cardiovascular disease. Pathways through which n-3 fatty acids may affect cardiovascular parameters are described in detail.PubMedCrossRef
12.•
go back to reference Larsson SC, Orsini N, Wolk A. Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis. Eur J Epidemiol. 2012;27(12):895–901. doi:10.1007/s10654-012-9748-9. Meta-analysis on dietary n-3 fatty acids and stroke risk that revealed a surprising gender difference.PubMedCrossRef Larsson SC, Orsini N, Wolk A. Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis. Eur J Epidemiol. 2012;27(12):895–901. doi:10.​1007/​s10654-012-9748-9. Meta-analysis on dietary n-3 fatty acids and stroke risk that revealed a surprising gender difference.PubMedCrossRef
13.
16.•
go back to reference Welch AA, Shakya-Shrestha S, Lentjes MA, Wareham NJ, Khaw KT. Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the product-precursor ratio [corrected] of alpha-linolenic acid to long-chain n-3 polyunsaturated fatty acids: results from the EPIC-Norfolk cohort. Am J Clin Nutr. 2010;92(5):1040–51. doi:10.3945/ajcn.2010.29457. This study indicated that the conversion of plant-derived ALA to EPA might be more efficient than previously thought.PubMedCrossRef Welch AA, Shakya-Shrestha S, Lentjes MA, Wareham NJ, Khaw KT. Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the product-precursor ratio [corrected] of alpha-linolenic acid to long-chain n-3 polyunsaturated fatty acids: results from the EPIC-Norfolk cohort. Am J Clin Nutr. 2010;92(5):1040–51. doi:10.​3945/​ajcn.​2010.​29457. This study indicated that the conversion of plant-derived ALA to EPA might be more efficient than previously thought.PubMedCrossRef
17.
go back to reference Welch AA, Bingham SA, Ive J, Friesen MD, Wareham NJ, Riboli E, et al. Dietary fish intake and plasma phospholipid n-3 polyunsaturated fatty acid concentrations in men and women in the European Prospective Investigation into Cancer-Norfolk United Kingdom cohort. Am J Clin Nutr. 2006;84(6):1330–9.PubMed Welch AA, Bingham SA, Ive J, Friesen MD, Wareham NJ, Riboli E, et al. Dietary fish intake and plasma phospholipid n-3 polyunsaturated fatty acid concentrations in men and women in the European Prospective Investigation into Cancer-Norfolk United Kingdom cohort. Am J Clin Nutr. 2006;84(6):1330–9.PubMed
20.
go back to reference Silva V, Barazzoni R, Singer P. Biomarkers of Fish Oil Omega-3 Polyunsaturated Fatty Acids Intake in Humans. Nutr Clin Prac: Off Publ Am Soc Parenter Enter Nutr. 2013. doi:10.1177/0884533613516144. Silva V, Barazzoni R, Singer P. Biomarkers of Fish Oil Omega-3 Polyunsaturated Fatty Acids Intake in Humans. Nutr Clin Prac: Off Publ Am Soc Parenter Enter Nutr. 2013. doi:10.​1177/​0884533613516144​.
21.
go back to reference Ocke MC, Bueno-de-Mesquita HB, Goddijn HE, Jansen A, Pols MA, van Staveren WA, et al. The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol. 1997;26(1):S37–48. doi:10.1093/ije/26.suppl_1.S37.PubMedCrossRef Ocke MC, Bueno-de-Mesquita HB, Goddijn HE, Jansen A, Pols MA, van Staveren WA, et al. The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol. 1997;26(1):S37–48. doi:10.​1093/​ije/​26.​suppl_​1.​S37.PubMedCrossRef
22.
23.
go back to reference Nagel G, Zoller D, Ruf T, Rohrmann S, Linseisen J. Long-term reproducibility of a food-frequency questionnaire and dietary changes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg cohort. Br J Nutr. 2007;98(1):194–200. doi:10.1017/S0007114507691636.PubMedCrossRef Nagel G, Zoller D, Ruf T, Rohrmann S, Linseisen J. Long-term reproducibility of a food-frequency questionnaire and dietary changes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heidelberg cohort. Br J Nutr. 2007;98(1):194–200. doi:10.​1017/​S000711450769163​6.PubMedCrossRef
24.
go back to reference Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005;135(2):310–6.PubMed Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005;135(2):310–6.PubMed
25.
27.•
go back to reference Kiefte-de Jong JC, Chowdhury R, Franco OH. Fish intake or omega-3 fatty acids: greater than the sum of all parts? Eur J Epidemiol. 2012;27(12):891–4. doi:10.1007/s10654-012-9757-8. Commentary on results from recent studies that suggest health benefits of fish consumption rather than n-3 fatty acid supplements. Several important methodological questions are raised by the authors.PubMedCrossRef Kiefte-de Jong JC, Chowdhury R, Franco OH. Fish intake or omega-3 fatty acids: greater than the sum of all parts? Eur J Epidemiol. 2012;27(12):891–4. doi:10.​1007/​s10654-012-9757-8. Commentary on results from recent studies that suggest health benefits of fish consumption rather than n-3 fatty acid supplements. Several important methodological questions are raised by the authors.PubMedCrossRef
28.
go back to reference Wennberg M, Bergdahl IA, Hallmans G, Norberg M, Lundh T, Skerfving S, et al. Fish consumption and myocardial infarction: a second prospective biomarker study from northern Sweden. Am J Clin Nutr. 2011;93(1):27–36. doi:10.3945/ajcn.2010.29408.PubMedCrossRef Wennberg M, Bergdahl IA, Hallmans G, Norberg M, Lundh T, Skerfving S, et al. Fish consumption and myocardial infarction: a second prospective biomarker study from northern Sweden. Am J Clin Nutr. 2011;93(1):27–36. doi:10.​3945/​ajcn.​2010.​29408.PubMedCrossRef
29.•
go back to reference Wennberg M, Stromberg U, Bergdahl IA, Jansson JH, Kauhanen J, Norberg M, et al. Myocardial infarction in relation to mercury and fatty acids from fish: a risk-benefit analysis based on pooled Finnish and Swedish data in men. Am J Clin Nutr. 2012;96(4):706–13. doi:10.3945/ajcn.111.033795. Excellent study from Scandinavia, in which cardiovascular risks and benefits associated with habitual fish intake were assessed.PubMedCrossRef Wennberg M, Stromberg U, Bergdahl IA, Jansson JH, Kauhanen J, Norberg M, et al. Myocardial infarction in relation to mercury and fatty acids from fish: a risk-benefit analysis based on pooled Finnish and Swedish data in men. Am J Clin Nutr. 2012;96(4):706–13. doi:10.​3945/​ajcn.​111.​033795. Excellent study from Scandinavia, in which cardiovascular risks and benefits associated with habitual fish intake were assessed.PubMedCrossRef
32.
go back to reference Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS, et al. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003;107(10):1372–7.PubMedCrossRef Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS, et al. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003;107(10):1372–7.PubMedCrossRef
33.
go back to reference Darmon N, Drewnowski A. Does social class predict diet quality? Am J Clin Nutr. 2008;87(5):1107–17.PubMed Darmon N, Drewnowski A. Does social class predict diet quality? Am J Clin Nutr. 2008;87(5):1107–17.PubMed
36.•
go back to reference Orlich MJ, Singh PN, Sabate J, Jaceldo-Siegl K, Fan J, Knutsen S, et al. Vegetarian dietary patterns and mortality in Adventist Health Study 2. JAMA Int Med. 2013;173(13):1230–8. doi:10.1001/jamainternmed.2013.6473. Highly interesting cohort study from the USA indicating that fish intake in addition to a vegetarian diet might lower the risk of mortality.CrossRef Orlich MJ, Singh PN, Sabate J, Jaceldo-Siegl K, Fan J, Knutsen S, et al. Vegetarian dietary patterns and mortality in Adventist Health Study 2. JAMA Int Med. 2013;173(13):1230–8. doi:10.​1001/​jamainternmed.​2013.​6473. Highly interesting cohort study from the USA indicating that fish intake in addition to a vegetarian diet might lower the risk of mortality.CrossRef
38.
39.
go back to reference Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666):757–61.PubMedCrossRef Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666):757–61.PubMedCrossRef
41.
go back to reference Tanaka K, Ishikawa Y, Yokoyama M, Origasa H, Matsuzaki M, Saito Y, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke. 2008;39(7):2052–8. doi:10.1161/STROKEAHA.107.509455.PubMedCrossRef Tanaka K, Ishikawa Y, Yokoyama M, Origasa H, Matsuzaki M, Saito Y, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke. 2008;39(7):2052–8. doi:10.​1161/​STROKEAHA.​107.​509455.PubMedCrossRef
44.•
go back to reference Kromhout D. Omega-3 fatty acids and coronary heart disease. The final verdict? Curr Opin Lipidol. 2012;23(6):554–9. doi:10.1097/MOL.0b013e328359515f. This review provides an outline of the recent evidence on n-3 fatty acids, fish intake and CHD risk from observational studies and randomized trials.PubMedCrossRef Kromhout D. Omega-3 fatty acids and coronary heart disease. The final verdict? Curr Opin Lipidol. 2012;23(6):554–9. doi:10.​1097/​MOL.​0b013e328359515f​. This review provides an outline of the recent evidence on n-3 fatty acids, fish intake and CHD risk from observational studies and randomized trials.PubMedCrossRef
45.
go back to reference Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369(9567):1090–8. doi:10.1016/S0140-6736(07)60527-3.PubMedCrossRef Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369(9567):1090–8. doi:10.​1016/​S0140-6736(07)60527-3.PubMedCrossRef
46.
go back to reference Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012;33(1):159–71. doi:10.1016/j.cct.2011.09.009.PubMedCentralPubMedCrossRef Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012;33(1):159–71. doi:10.​1016/​j.​cct.​2011.​09.​009.PubMedCentralPubMedCrossRef
50.
go back to reference Hoekstra J, Hart A, Owen H, Zeilmaker M, Bokkers B, Thorgilsson B, et al. Fish, contaminants and human health: quantifying and weighing benefits and risks. Food Chem Toxicol: Int J Publ Br Ind Biol Res Assoc. 2013;54:18–29. doi:10.1016/j.fct.2012.01.013.CrossRef Hoekstra J, Hart A, Owen H, Zeilmaker M, Bokkers B, Thorgilsson B, et al. Fish, contaminants and human health: quantifying and weighing benefits and risks. Food Chem Toxicol: Int J Publ Br Ind Biol Res Assoc. 2013;54:18–29. doi:10.​1016/​j.​fct.​2012.​01.​013.CrossRef
Metadata
Title
Fish Consumption and the Risk of Stroke
Author
Tilman Kühn
Publication date
01-06-2014
Publisher
Springer US
Published in
Current Nutrition Reports / Issue 2/2014
Electronic ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-014-0075-5

Other articles of this Issue 2/2014

Current Nutrition Reports 2/2014 Go to the issue

Cardiovascular Disease (JH Goedecke, Section Editor)

Dairy and Cardiovascular Disease: A Review of Recent Observational Research

Neurological Disease and Cognitive Function (G Logroscino, Section Editor)

Prevention of Late-life Cognitive Disorders: Diet-Related Factors, Dietary Patterns, and Frailty Models

Neurological Disease and Cognitive Function (G Logroscino, Section Editor)

Malnutrition and Neurodegenerative Diseases

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.